4.6 Article

ASIP COTRAN EARLY CAREER INVESTIGATOR AWARD LECTURE Understanding the Oxygen-Sensing Pathway and Its Therapeutic Implications in Diseases

Journal

AMERICAN JOURNAL OF PATHOLOGY
Volume 190, Issue 8, Pages 1584-1595

Publisher

ELSEVIER SCIENCE INC
DOI: 10.1016/j.ajpath.2020.04.003

Keywords

-

Categories

Funding

  1. National Cancer Institute [R01CA211732, R21CA223675]
  2. American Cancer Society Research Scholar Award [TBE-132187]
  3. Department of Defense Kidney Cancer Research Program [W81XWH1910813]
  4. Cancer Prevention and Research Institute of Texas (CPRIT) [RR190058]
  5. U.S. Department of Defense (DOD) [W81XWH1910813] Funding Source: U.S. Department of Defense (DOD)

Ask authors/readers for more resources

Maintaining oxygen homeostasis is a most basic cellular process for adapting physiological oxygen variations, and its abnormality typically leads to various disorders in the human body. The key molecules of the oxygen-sensing system include the transcriptional regulator hypoxia-inducible factor (HIF), which controls a wide range of oxygen responsive target genes (eg, EPO and VEGF), certain members of the oxygen/2-oxoglutarate-dependent dioxygenase family, including the HIF proline hydroxylase (PHD, alias EGLN), and an E3 ubiquitin ligase component for HIF destruction called von Hippel-Lindau. In this review, we summarize the physiological role and highlight the pathologic function for each protein of the oxygen-sensing system. A better understanding of their molecular mechanisms of action will help uncover novel therapeutic targets and develop more effective treatment approaches for related human diseases, including cancer.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.6
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available